The pursuit of IoT innovation led Sysmex to adopt ThingWorx. The Industrial Innovation Platform enabled Sysmex to greatly expand the availability of product data and implement transformative connected solutions that were previously beyond reach. Prior to the XW-100, virtually all hematology analyzers required skilled clinical personnel to perform blood sample analysis and validate results. This ground-breaking innovation enables blood tests to be safely performed by a broader range of practitioners, improving access to and speed of care.
“It is no longer going to be sufficient to sell instruments. You’ve got to put a wrapper around them that demonstrates their value to the patient experience.”
Andy Hay, Chief Operating Officer, Sysmex America
